Dr Reddy's

Teva holding off launch of opioid addiction drug
Teva holding off launch of opioid addiction drug
Pharmaforum
Teva Pharmaceutical
opioids
opioid addiction
generics
Dr Reddy's
Suboxone
Indivior
Flag link:
Indivior's shares soar 33 percent after U.S. court blocks sale of rival generic
Indivior's shares soar 33 percent after U.S. court blocks sale of rival generic
Reuters
Indivior
opioid addiction
generics
Suboxone Film
Dr Reddy's
Flag link:
U.S. District Court rules in favor of Lilly's Alimta patent
U.S. District Court rules in favor of Lilly's Alimta patent
Yahoo/Reuters
Eli Lilly
Alimta
Hospira
Dr Reddy's
generics
patents
Flag link:
Indivior Files Complaints Asserting New Suboxone Film Patent Against ANDA-Filers
Indivior Files Complaints Asserting New Suboxone Film Patent Against ANDA-Filers
CP Wire
Individor
Suboxone Film
patents
Dr Reddy's
Actavis
Par Pharmaceutical
Teva Pharmaceutical
Alvogen
Flag link:
The difficult momentum of Indian pharma sector
The difficult momentum of Indian pharma sector
GoinPharma
India
generics
Sun Pharma
Cipla
Dr Reddy's
Lupin
Flag link:
Dr. Reddy's sells off psoriasis candidate in out-licensing deal
Dr. Reddy's sells off psoriasis candidate in out-licensing deal
BioPharma Dive
Dr Reddy's
psoriasis
out-licensing
DFD-06
Encore Dermatology
Flag link:
Dr. Reddy's revives ex-Novartis OTC brands with slate of new ad campaigns
Dr. Reddy's revives ex-Novartis OTC brands with slate of new ad campaigns
Fierce Pharma
Dr Reddy's
Novartis
OTC
drug ads
Flag link:
7 Pharma Plays With Emerging Market Potential
7 Pharma Plays With Emerging Market Potential
Barron's
emerging markets
Pfizer
GSK
Sanofi
Eli Lilly
Bristol-Myers Squibb
AstraZeneca
Dr Reddy's
Flag link:
BioMarin sues to stop generic version of its $90K-a-year drug
BioMarin sues to stop generic version of its $90K-a-year drug
Bizjournals.com
Biomarin
generics
Kuvan
Dr Reddy's
Flag link:
Dr. Reddy's Labs Launches Generic Osteoporosis Drug Tablets in the US
Dr. Reddy's Labs Launches Generic Osteoporosis Drug Tablets in the US
Yahoo
Dr Reddy's
generics
osteoporosis
Eli Lilly
Evista
Flag link:
Dr Reddy's and Amgen broaden marketing collaboration
Dr Reddy's and Amgen broaden marketing collaboration
BioPharma Dive
Amgen
Dr Reddy's
India
Xgeva
Prolia
Vectibix
Flag link:
Dr. Reddy's breaks off marketing partnership with Glaxo
Dr. Reddy's breaks off marketing partnership with Glaxo
BioPharma Dive
Dr Reddy's
GSK
emerging markets
India
Flag link:
Dr. Reddy's snaps up eight generics from Teva for $350 million
Dr. Reddy's snaps up eight generics from Teva for $350 million
BioPharma Dive
Dr Reddy's
Teva Pharmaceuticals
generics
M&A
Flag link:
Dr. Reddy's Receives FDA Tentative Approval For Zenavod Capsules
Dr. Reddy's Receives FDA Tentative Approval For Zenavod Capsules
Yahoo/Benzinga
Dr Reddy's
FDA
Zenavod
Rosacea
Flag link:
Dr. Reddy’s to change the color of its generic heartburn drug Nexium
Dr. Reddy’s to change the color of its generic heartburn drug Nexium
Stat
Dr Reddy's
generics
Nexium
AstraZeneca
Flag link:
Dr. Reddy's strikes back at AstraZeneca in purple pill courtroom battle
Dr. Reddy's strikes back at AstraZeneca in purple pill courtroom battle
Fierce Pharma
Dr Reddy's
AstraZeneca
Nexium
generics
Flag link:
AstraZeneca holds on to purple Nexium trademark with early court win
AstraZeneca holds on to purple Nexium trademark with early court win
Fierce Pharma Marketing
AstraZeneca
Nexium
trademark
Dr Reddy's
generics
Flag link:
What Companies Amgen May Be Eyeing For M&A?
What Companies Amgen May Be Eyeing For M&A?
Bidness, ETC
Amgen
M&A
Seattle Genetics
Alnylam
Dr Reddy's
Flag link:
Dr. Reddy's feels FDA heat, gets warning letter for three plants
Dr. Reddy's feels FDA heat, gets warning letter for three plants
Fierce Pharma
Dr Reddy's
FDA
warnings
drug manufacturing
India
Flag link:
AstraZeneca sees red over a ‘purple pill’ and sues a generic drug maker
AstraZeneca sees red over a ‘purple pill’ and sues a generic drug maker
Pharmalot
AstraZeneca
generics
Nexium
Dr Reddy's
Flag link:

Pages